HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma (vol 20, 537, 2022)

被引：1
|
作者：
Jia, Chuiming [1 ]
Guo, Yiwei [1 ]
Chen, Yao [1 ]
Wang, Xinya [1 ]
Xu, Qiuting [1 ]
Zhang, Yu [2 ]
Quan, Lina [1 ]
机构：
[1] Harbin Med Univ, Canc Hosp, Hematol Dept, Harbin, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Immunol Dept, Harbin, Heilongjiang, Peoples R China
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2023年 / 21卷 / 01期
关键词：
D O I：
10.1186/s12967-023-03904-2
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] RBM15-mediated m6A modification of XPR1 promotes the malignant progression of lung adenocarcinoma
    Sun, Changpeng
    Guan, Hongjun
    Li, Jinjin
    Gu, Yinfeng
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [32] METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression (vol 46, 163, 2021)
    Zhang, Yongxi
    Liu, Shuyuan
    Zhao, Tiesuo
    Dang, Chengxue
    ONCOLOGY REPORTS, 2023, 49 (04)
  • [33] YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B
    Wang, Shijiang
    Nie, Jiangbo
    Xu, Kaiying
    Liu, Yangyang
    Tong, Weilai
    Li, Anan
    Zuo, Wei
    Liu, Zhili
    Yang, Feng
    AGING-US, 2023, 15 (18): : 9590 - 9613
  • [34] Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma
    Wang, Wei
    Li, Shengwei
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024, 19 (05) : 652 - 665
  • [35] METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification (vol 9, 784719, 2022)
    Zhou, Xinying
    Yang, Yang
    Li, Yuejun
    Liang, Guojun
    Kang, Dawei
    Zhou, Bing
    Li, Qingchu
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [36] HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
    Li, Ke
    Gong, Quan
    Xiang, Xu-Dong
    Guo, Gang
    Liu, Jia
    Zhao, Li
    Li, Jun
    Chen, Nan
    Li, Heng
    Zhang, Li-Juan
    Zhou, Chun-Yan
    Wang, Zhi-Yong
    Zhuang, Li
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [37] HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
    Ke Li
    Quan Gong
    Xu-Dong Xiang
    Gang Guo
    Jia Liu
    Li Zhao
    Jun Li
    Nan Chen
    Heng Li
    Li-Juan Zhang
    Chun-Yan Zhou
    Zhi-Yong Wang
    Li Zhuang
    Journal of Translational Medicine, 21
  • [38] METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy
    Jiang, Ling
    Liu, Xueqi
    Hu, Xueru
    Gao, Li
    Zeng, Hanxu
    Wang, Xian
    Huang, Yuebo
    Zhu, Wei
    Wang, Jianan
    Wen, Jiagen
    Meng, Xiaoming
    Wu, Yonggui
    MOLECULAR THERAPY, 2022, 30 (04) : 1721 - 1740
  • [39] TRPM4 mRNA stabilization by METTL3-mediated m6A modification promotes calcific aortic valve inflammation
    Wu, Jianguo
    Huang, Haozong
    Yang, Wenkai
    Xue, Tufeng
    Wang, Wenjuan
    Zheng, Guang-Di
    HELIYON, 2024, 10 (11)
  • [40] METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10
    Jingli Cai
    Zheng Cui
    Jingyi Zhou
    Bosen Zhang
    Ruiqi Lu
    Youcheng Ding
    Hai Hu
    Cancer Cell International, 22
12345